Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050800 · ClinicalTrials.gov registry record · Early Phase 1
Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety
A Early Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT04050800 is a Early Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 5 participants.
The verdict
NCT04050800, a Early Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This will be a Phase 1, open label, imaging study of radiochemical and radiation safety in healthy volunteers. Using positron emission tomography (PET) and in-line computed tomography (CT), the whole body (WB) biokinetics of Carbon-11 butanol will be quantified with serial scans acquired every 3 minutes for two hours. Vital signs (VS), electrocardiograms (ECGs) and clinical laboratory tests of intrernal organ function will be acquired before and at several timepoints after administration of the radiopharmaceutical. Radiation exposures will be estimated with the MIRD Formalism.
Interventions
- DRUG Carbon 11 Butanol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2021-01-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04050800
The ClinicalTrials.gov registry entry for NCT04050800 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carbon 11 Butanol is the first listed.
NCT04050800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04050800 about?
NCT04050800 is a clinical study titled "Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety". This will be a Phase 1, open label, imaging study of radiochemical and radiation safety in healthy volunteers. Using positron emission tomography (PET) and in-line computed tomography (CT), the whole body (WB) biokinetics of Carbon-11 butanol will be quantified with serial scans acquired every 3 min...
What is the current status of trial NCT04050800?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2020-09-17. Estimated completion is 2021-01-05.
What interventions are being tested in trial NCT04050800?
The interventions under investigation include: Carbon 11 Butanol (DRUG).
Who is sponsoring clinical trial NCT04050800?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.